The Institute for Neurosciences of Montpellier (INM) is dedicated to basic research on transduction, integration and disorders of sensory and motor systems. The INM houses several teams working on vision, hearing, somatosensory wiring and myelination. Molecular to systems level investigations are carried-out through core technical facilities (Functional analysis, histology, photonic imaging and electron microscopy), which are open to academic and private users outside the INM. Our outputs favor the development of new treatments for sensory and motor deficits, with a strong interest in inherited retinal and optic blindness, auditory neuropathies (deafness and tinnitus), neurodegenerative diseases (amyotrophic lateral sclerosis, giant axonal neuropathy), somatosensation disorders (touch and pain) and glial pathologies (gliomas, GAN and Charcot Marie Tooth disease). Translational research relies on strong interactions with the clinical departments (Ophthalmology, ENT, Neurology, Neurosurgery) and start-up companies, which stem emerged from our laboratory (Sensorion, Horama, BetaInov, Biodol therapeutics).
The mutated form of SOD1 causing Charcot's Disease differentially disrupts motor neurons ans muscle
A new component of the synapse, TMEM16F, involved in ALS
INM joins the CRISPR/Cas community
Mitochondrial DNA is implicated in a new surprising phenotype
Genetic instability in iPSc